Return On Equity ratio Analysis of Arcturus Therapeutics HLDG Inc. - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY ROE
Period Ending - Dec-23
Very Good ROE
35.27
Period Ending - Dec-22
Poor ROE
3.46
Growth
919.70 %
Trailing Twelve Months ROE
Period Ending - Dec-23
Very Poor ROE
-36.16
Most recent Quarter ROE
Period Ending - Mar-24
Very Poor ROE
-10.16
ROE Analysis of Arcturus Therapeutics HLDG Inc.
| ROE Ratio of Arcturus Therapeutics HLDG Inc. with value of -36.16 means is not able to effectively utilize its Shareholders Fund in order to generate a profit in trailing twelve months. |
| ROE Ratio of Arcturus Therapeutics HLDG Inc. with value of -10.16 means is not able to effectively utilize its Shareholders Fund in order to generate a profit in latest Quarter ending on Mar-24. |
| ROE Ratio of ARCT rose handsomely by 919.70 % this year. |
| ROE Ratio with value of 35.27 was highest in Year Dec-23 in last Five Years. |
| ROE Ratio with value of -100.77 was lowest in Year Dec-19 in last Five Years. |
| Latest ROE Ratio with value of 35.27 is Greater than Average ROE of -33.90 in last five years. |
| ROE of Arcturus Therapeutics HLDG Inc. is negative because of poor net profit in Trailing Twelve Months ended on Mar-24. |
Other ROE Related Info of ARCT that may interest you.
Arcturus Therapeutics HLDG Inc. Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| ARCT | 38.81 | 38.48 | 0.858 % | Biotechnology |
Defination of Return On Equity
The Return on Equity (ROE) is a profitability metric that measures a company's ability to generate profits using its shareholder's fund. ROE is calculated by dividing Net Income by Shareholders' Fund. more ..
ROE Related Ratios
| ReturnOnAsset | NetProfitMargin |
Tsr Profitability Index
| Poor Profitability Stock | |
FY - Historical Return On Equity of Arcturus Therapeutics HLDG Inc.
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| ROE | 35.27 | 3.46 | -89.25 | -18.19 | -100.77 | -159.69 | -32.26 |
| Change | 919.70 % | 103.88 % | -390.54 % | 81.95 % | 36.90 % | -395.01 % | 38.07 % |
FY Chart of Return On Equity of Arcturus Therapeutics HLDG Inc.
Note : All Data Generated at the End of Trading Hours (EOD Data)